MGNX240719C10000
- 0.10
- 0.000.00%
Macrogenics Newsroom
Investigation Into MacroGenics (MGNX) Announced by Hagens Berman
One MacroGenics Insider Raised Stake By 83% In Previous Year
MacroGenics (MGNX) Investigating Three of Five Patient Deaths in TAMARACK Study of Vobra Duo, Stock Flat After May 10, 2024 Crash Hagens Berman
MacroGenics (NASDAQ:MGNX Shareholders Incur Further Losses as Stock Declines 16% This Week, Taking Three-year Losses to 82%
MacroGenics to Participate in Upcoming Investor Conference
Shareholders in MacroGenics (NASDAQ:MGNX) Are in the Red If They Invested Three Years Ago
Express News | Millennium Management LLC Reports 5.1% Passive Stake in MacroGenics Inc as of June 3 - SEC Filing
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Demystifying Macrogenics: Insights From 14 Analyst Reviews
Macrogenics Is Maintained at Buy by BTIG
Macrogenics Price Target Cut to $9.00/Share From $24.00 by BTIG
Express News | BTIG Maintains Buy on Macrogenics, Lowers Price Target to $9
B.Riley Financial Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $18
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Iovance Biotherapeutics (IOVA)
Express News | MacroGenics Inc : Btig Cuts Target Price to $9 From $24
BTIG Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $9
Express News | MacroGenics Inc : Citigroup Cuts Target Price to $16 From $25
Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Bruker (BRKR)
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
FFIE, OGEN and CCLD Among Mid-day Movers